- Home
- DBVT vs HMST Comparison
DBVT vs HMST Comparison
Compare DBVT & HMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBVT
- HMST
- Stock Information
- Founded
- DBVT 2002
- HMST 1921
- Country
- DBVT France
- HMST United States
- Employees
- DBVT N/A
- HMST N/A
- Industry
- DBVT Biotechnology: Biological Products (No Diagnostic Substances)
- HMST Major Banks
- Sector
- DBVT Health Care
- HMST Finance
- Exchange
- DBVT Nasdaq
- HMST Nasdaq
- Market Cap
- DBVT 289.8M
- HMST 249.4M
- IPO Year
- DBVT N/A
- HMST 2012
- Fundamental
- Price
- DBVT $9.00
- HMST $12.91
- Analyst Decision
- DBVT Buy
- HMST Hold
- Analyst Count
- DBVT 4
- HMST 3
- Target Price
- DBVT $14.81
- HMST $14.17
- AVG Volume (30 Days)
- DBVT 27.3K
- HMST 67.4K
- Earning Date
- DBVT 07-29-2025
- HMST 07-28-2025
- Dividend Yield
- DBVT N/A
- HMST N/A
- EPS Growth
- DBVT N/A
- HMST N/A
- EPS
- DBVT N/A
- HMST N/A
- Revenue
- DBVT $3,800,000.00
- HMST $78,496,000.00
- Revenue This Year
- DBVT $1,743.46
- HMST $161.80
- Revenue Next Year
- DBVT $1,044.34
- HMST $8.90
- P/E Ratio
- DBVT N/A
- HMST N/A
- Revenue Growth
- DBVT N/A
- HMST N/A
- 52 Week Low
- DBVT $2.21
- HMST $8.41
- 52 Week High
- DBVT $12.78
- HMST $16.10
- Technical
- Relative Strength Index (RSI)
- DBVT 44.06
- HMST 47.50
- Support Level
- DBVT $8.51
- HMST $12.46
- Resistance Level
- DBVT $10.93
- HMST $13.83
- Average True Range (ATR)
- DBVT 0.71
- HMST 0.44
- MACD
- DBVT -0.15
- HMST -0.07
- Stochastic Oscillator
- DBVT 20.25
- HMST 32.85
About DBVT DBV Technologies S.A.
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.
About HMST HomeStreet Inc.
HomeStreet Inc is a commercial bank. It provides commercial loans and consumer loans including mortgage loans, deposit products, private banking, and cash management services. The company loan products include commercial business loans and agriculture loans, consumer loans, single family residential mortgages, loans secured by commercial real estate and construction loans for residential and commercial real estate projects.